These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18023708)

  • 1. Prevention of VTE in multiple myeloma patients.
    Zamagni E; Valdrè L; Palareti G; Cavo M
    Thromb Res; 2007; 120 Suppl 2():S133-6. PubMed ID: 18023708
    [No Abstract]   [Full Text] [Related]  

  • 2. Venous thromboembolism in multiple myeloma: current perspectives in pathogenesis.
    Uaprasert N; Voorhees PM; Mackman N; Key NS
    Eur J Cancer; 2010 Jul; 46(10):1790-9. PubMed ID: 20385482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma.
    Wun T; White RH
    Thromb Res; 2010 Apr; 125 Suppl 2():S96-102. PubMed ID: 20434017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloma and thrombotic complications.
    Tzoran I; Brenner B; Hoffman R
    Minerva Med; 2013 Apr; 104(2):155-60. PubMed ID: 23514991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New oral anticoagulants might be useful thromboprophylactic agents in multiple myeloma patients on immunomodulatory agents.
    Aguilar C; Lucía JF
    Blood Coagul Fibrinolysis; 2010 Dec; 21(8):776-8. PubMed ID: 21042059
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy.
    Musallam KM; Dahdaleh FS; Shamseddine AI; Taher AT
    Thromb Res; 2009 Mar; 123(5):679-86. PubMed ID: 18992924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and treatment of venous thromboembolism during pregnancy.
    Weitz JI
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S22-6. PubMed ID: 19213066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients.
    Prandoni P; Samama MM
    Br J Haematol; 2008 May; 141(5):587-97. PubMed ID: 18422787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Venous thromboembolism prophylaxis in internal medicine].
    Malý J; Widimský J; Dulícek P
    Vnitr Lek; 2009 Mar; 55(3):190-5. PubMed ID: 19378845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines.
    Petersen LJ
    Cancer Treat Rev; 2009 Dec; 35(8):754-64. PubMed ID: 19762155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism in at-risk pregnant women: a review.
    Duhl AJ
    J Reprod Med; 2008 Sep; 53(9):657-66. PubMed ID: 18839817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboprophylaxis in multiple myeloma.
    Thalambedu N; Al Hadidi S
    Leuk Lymphoma; 2022 Dec; 63(12):2807-2815. PubMed ID: 35759648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and treatment of venous thromboembolism among patients with cancer: the American Society of Clinical Oncology Guidelines.
    Lyman GH; Kuderer NM;
    Thromb Res; 2010 Apr; 125 Suppl 2():S120-7. PubMed ID: 20433991
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing the risk of venous thromboembolism in multiple myeloma.
    Sanfilippo KM
    Thromb Res; 2020 Jul; 191 Suppl 1():S74-S78. PubMed ID: 32736783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First episode and recurrent venous thromboembolism: who is identifiably at risk?
    Liem TK; Deloughery TG
    Semin Vasc Surg; 2008 Sep; 21(3):132-8. PubMed ID: 18774448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updates on thrombotic events associated with multiple myeloma.
    Fotiou D; Gavriatopoulou M; Ntanasis-Stathopoulos I; Migkou M; Dimopoulos MA; Terpos E
    Expert Rev Hematol; 2019 May; 12(5):355-365. PubMed ID: 30957573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rivaroxaban for the prevention of venous thromboembolism following major orthopedic surgery: the RECORD trials.
    Ageno W
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):569-76. PubMed ID: 19505271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unanswered questions in venous thromboembolism.
    Weitz JI
    Thromb Res; 2009; 123 Suppl 4():S2-S10. PubMed ID: 19303498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboprophylaxis in patients with multiple myeloma.
    Wang TF; Delluc A
    Br J Haematol; 2020 Aug; 190(4):493-494. PubMed ID: 32395827
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of venous thromboembolism in hospitalized medical patients.
    Lenchus JD; Jaffer AK
    Mt Sinai J Med; 2008 Oct; 75(5):449-53. PubMed ID: 18828167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.